Safety, Tolerability and Antimalarial Activity of Single Doses of OZ439 and PQP

NCT03542149 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Malaria

Interventions

DRUG: 480 mg Piperaquine phosphate
DRUG: 640 mg Piperaquine phosphate
DRUG: 200 mg OZ 439
DRUG: 400 mg OZ 439
DRUG: 800 mg OZ 439
DRUG: 960 mg PQP
DRUG: 320 mg PQP

Sponsor

Medicines for Malaria Venture

Collaborators

[object Object]
[object Object]
[object Object]